Oncogenic Potential of a Dominant Negative Mutant of Interferon Regulatory Factor 3
Open Access
- 1 April 2003
- journal article
- Published by Elsevier
- Vol. 278 (17), 15272-15278
- https://doi.org/10.1074/jbc.m205792200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Interferon regulatory factor-3 is an in vivo target of DNA-PKProceedings of the National Academy of Sciences, 2002
- The evolution of diverse biological responses to DNA damage: insights from yeast and p53Nature Cell Biology, 2001
- Proliferation, cell cycle and apoptosis in cancerNature, 2001
- Apoptosis is promoted by the dsRNA‐activated factor (DRAF1) during viral infection independent of the action of interferon or p53The FASEB Journal, 2001
- Surfing the p53 networkNature, 2000
- Signaling Pathways to the Assembly of an Interferon-β EnhanceosomePublished by Elsevier ,2000
- Activation of Interferon Regulatory Factor 3 in Response to DNA-damaging AgentsJournal of Biological Chemistry, 1999
- Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53Molecular and Cellular Biology, 1999
- The complexity of p53 modulation: emerging patterns from divergent signalsGenes & Development, 1998
- Structure and Function of the Interferon- EnhanceosomeCold Spring Harbor Symposia on Quantitative Biology, 1998